Stay updated on Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedAdded new sections in the study record history for Adverse Events, Outcome Measures (Results), Participant Flow, and Study Status, plus related Document Section updates. A deletion occurred on 2024-12-02.SummaryDifference0.9%

- Check15 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 was removed from the history page, reflecting a minor administrative update to the version list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check23 days agoChange DetectedThe page history shows a new revision v3.3.1 replacing the previous v3.2.0. There are no visible changes to study data or page content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check30 days agoChange DetectedRemoved the banner warning about a lapse in government funding and links to operating-status information (cc.nih.gov and opm.gov) that previously appeared at the top of the page.SummaryDifference0.7%

- Check44 days agoChange DetectedThe new screenshot shows a very similar Record History page with a slightly adjusted layout and header labels, but no new study data or status changes are visible. The update appears to be a minor UI/visual change rather than a substantive modification to the study record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check72 days agoChange DetectedUpdated operating status notice and a new release version (v3.2.0) replacing the old v3.1.0.SummaryDifference12%

Stay in the know with updates to Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page.